354 related articles for article (PubMed ID: 2918589)
21. Calcitonin-gene-related peptide: a possible role in human penile erection and its therapeutic application in impotent patients.
Stief CG; Wetterauer U; Schaebsdau FH; Jonas U
J Urol; 1991 Oct; 146(4):1010-4. PubMed ID: 1895414
[TBL] [Abstract][Full Text] [Related]
22. Clinical reliability of multi-drug intracavernous vasoactive pharmacotherapy for diabetic impotence.
Montorsi F; Guazzoni G; Bergamaschi F; Zucconi M; Rigatti P; Pizzini G; Miani A; Pozza G
Acta Diabetol; 1994 Apr; 31(1):1-5. PubMed ID: 8043890
[TBL] [Abstract][Full Text] [Related]
23. Determinants of satisfactory rigidity after intracavernosal injection with prostaglandin E1 in men with erectile failure.
Purvis K; Brekke I; Christiansen E
Int J Impot Res; 1996 Mar; 8(1):9-16. PubMed ID: 8735188
[TBL] [Abstract][Full Text] [Related]
24. Intracavernous self-injection with phentolamine and papaverine for the treatment of impotence.
Gasser TC; Roach RM; Larsen EH; Madsen PO; Bruskewitz RC
J Urol; 1987 Apr; 137(4):678-80. PubMed ID: 3550149
[TBL] [Abstract][Full Text] [Related]
25. Intracavernous injections: still the gold standard for treatment of erectile dysfunction in elderly men.
Richter S; Vardi Y; Ringel A; Shalev M; Nissenkorn I
Int J Impot Res; 2001 Jun; 13(3):172-5. PubMed ID: 11525316
[TBL] [Abstract][Full Text] [Related]
26. Comparative study of papaverine plus phentolamine versus prostaglandin E1 in erectile dysfunction.
Bechara A; Casabé A; Chéliz G; Romano S; Rey H; Fredotovich N
J Urol; 1997 Jun; 157(6):2132-4. PubMed ID: 9146599
[TBL] [Abstract][Full Text] [Related]
27. Transurethral alprostadil as therapy for patients who withdrew from or failed prior intracavernous injection therapy.
Engel JD; McVary KT
Urology; 1998 May; 51(5):687-92. PubMed ID: 9610580
[TBL] [Abstract][Full Text] [Related]
28. Intracavernous drug-induced erections in the management of male erectile dysfunction: experience with 100 patients.
Sidi AA; Cameron JS; Duffy LM; Lange PH
J Urol; 1986 Apr; 135(4):704-6. PubMed ID: 2421014
[TBL] [Abstract][Full Text] [Related]
29. Treatment of impotence by intrapenile injections. A comparison of papaverine versus papaverine and phentolamine: a double-blind, crossover trial.
Keogh EJ; Watters GR; Earle CM; Carati CJ; Wisniewski ZS; Tulloch GS; Lord DJ
J Urol; 1989 Sep; 142(3):726-8. PubMed ID: 2671414
[TBL] [Abstract][Full Text] [Related]
30. [Clinical evaluation of intracavernous self-injection of vasoactive drugs for impotence: a long-term follow-up observation].
Hayashi S; Iwai Y; Yasumoto R; Matsuda J; Kawano M; Omachi T; Kono T; Yamamoto S; Sakakura T; Minami H
Hinyokika Kiyo; 1994 Jan; 40(1):37-41. PubMed ID: 7509119
[TBL] [Abstract][Full Text] [Related]
31. Intracavernous injections for impotence.
Med Lett Drugs Ther; 1987 Oct; 29(751):95-6. PubMed ID: 3670212
[No Abstract] [Full Text] [Related]
32. Pharmacologically induced erections among geriatric men.
Kerfoot WW; Carson CC
J Urol; 1991 Oct; 146(4):1022-4. PubMed ID: 1895417
[TBL] [Abstract][Full Text] [Related]
33. [Action of vasoactive drugs in male sexual impotence].
Morales JC; Elizondo B
Arch Esp Urol; 1989; 42(9):900-4. PubMed ID: 2624491
[TBL] [Abstract][Full Text] [Related]
34. Experience with intracavernosal tri-mixture for the management of neurogenic erectile dysfunction.
Chao R; Clowers DE
Arch Phys Med Rehabil; 1994 Mar; 75(3):276-8. PubMed ID: 8129578
[TBL] [Abstract][Full Text] [Related]
35. [Intracavernous pharmacotherapy for organic impotence in the elderly].
Richter S; Shalev M; Nissenkorn I
Harefuah; 1990 Aug; 119(3-4):66-7. PubMed ID: 2227669
[TBL] [Abstract][Full Text] [Related]
36. [Prostaglandin E1 injection in erectile dysfunction. Current diagnostic and therapeutic possibilities].
Schrey A
Fortschr Med; 1990 Oct; 108(30):577-80. PubMed ID: 2245960
[TBL] [Abstract][Full Text] [Related]
37. [3 years' experience with intracavernous auto-injection therapy].
Weiske WH
Urologe A; 1989 Sep; 28(5):253-6. PubMed ID: 2815435
[TBL] [Abstract][Full Text] [Related]
38. The pH analysis of papaverine-phentolamine and prostaglandin E1 for pharmacologic erection.
Seidmon EJ; Samaha AM
J Urol; 1989 Jun; 141(6):1458-9. PubMed ID: 2724447
[TBL] [Abstract][Full Text] [Related]
39. Papaverine plus prostaglandin E1 versus prostaglandin E1 alone for intracorporeal injection therapy.
Zaher TF
Int Urol Nephrol; 1998; 30(2):193-6. PubMed ID: 9607891
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic and therapeutic technology assessment. Vasoactive intracavernous pharmacotherapy for impotence: papaverine and phentolamine.
JAMA; 1990 Aug; 264(6):752-4. PubMed ID: 2374280
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
